SND1的转化调节在压力期间控制内皮质平衡
Zhenbo Han1, Gege Yan1, Jordan Jousma1
1Department of Pharmacology & Regenerative Medicine, University of Illinois College of Medicine, Chicago, Illinois, USA.
The Journal of clinical investigation
|February 3, 2025
概括
铁氨酸激酶抑制剂 (TKIs) 导致内皮压力. 我们发现,控制SND1 (葡萄球菌核酶和Tudor域含蛋白1) 的翻译可以防止TKI诱导的血管功能障碍.
科学领域:
- 心血管生物学 心血管生物学
- 分子瘤学分子瘤学
- 翻译医学是一种翻译医学.
背景情况:
- 氨酸激酶抑制剂 (TKIs) 是关键的癌症治疗方法,但可能导致心血管副作用.
- 内皮细胞经历TKIs的压力,影响血管健康.
- 在细胞应激期间,转化控制对基因表达调节至关重要.
研究的目的:
- 为了研究转化控制在内皮细胞的作用,在由sunitinib诱导的压力下.
- 为了确定特定的基因和途径参与sunitinib诱导的内皮功能障碍.
- 探索治疗策略,以减轻与TKI相关的血管毒性.
主要方法:
- 使用人类诱导的多能干细胞衍生的内皮细胞 (hiPSC-EC) 模型.
- 采用核糖体分析来分析翻译控制.
- 研究了mTORC1/4E-BP1通路和SND1基因表达.
- 在体中进行药物选和体外/体内验证.
主要成果:
- 苏尼提尼布治疗通过mTORC1/4E-BP1通路转化抑制了葡萄球菌核酶和图多域含蛋白1 (SND1).
- 抑制SND1会使内皮功能障碍恶化,而SND1过度表达则可以防止sunitinib的影响.
- SND1调节了UBE2N,它与RNF8/RNF168一起调节了DNA损伤的修复.
- 拉米普利尔,一种ACE抑制剂,可以防止sunitinib诱导的血管功能障碍,而不会影响抗癌疗效.
结论:
- 对SND1的转化控制是苏尼提尼布诱导的内皮功能障碍的一个关键机制.
- 针对SND1介导途径提供了一个潜在的治疗策略,以减少TKI心脏毒性.
- 拉米普利在预防苏尼提尼布诱导的血管损伤方面显示出有前途.
更多相关视频
相关概念视频
Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
Regulation of the Unfolded Protein Response
2.4K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.4K
Autoregulation of Blood Flow
2.1K
Autoregulation mechanisms are characterized by their inherent capacity for self-regulation without necessitating specific nervous stimulation or endocrine control. These mechanisms facilitate the adjustment of blood flow and, therefore, perfusion specific to each tissue region. This self-regulation encompasses chemical signals and myogenic controls.
Chemical Signaling in Autoregulation
Chemical signaling operates at the precapillary sphincter level, inciting either contraction or relaxation....
Chemical Signaling in Autoregulation
Chemical signaling operates at the precapillary sphincter level, inciting either contraction or relaxation....
2.1K
Neural Regulation of Blood Pressure
2.6K
The neural regulation of blood pressure involves intricate interactions between the autonomic nervous system (ANS) and cardiovascular system, ensuring adequate perfusion of tissues. This regulation primarily occurs through baroreceptor and chemoreceptor reflexes, involving both short-term and long-term mechanisms.
Baroreceptor Reflex
Baroreceptors, located in the carotid sinuses and aortic arch, detect changes in blood pressure. When blood pressure rises, these stretch-sensitive receptors...
Baroreceptor Reflex
Baroreceptors, located in the carotid sinuses and aortic arch, detect changes in blood pressure. When blood pressure rises, these stretch-sensitive receptors...
2.6K
Regulation of Nuclear Protein Sorting
2.4K
Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
2.4K


